Insider Trends: 90-Day Insider Buying Trend at Bristol-Myers Squibb Interrupted with Disposition of Shares
04:59 PM EDT, 05/07/2021 (MT Newswires) -- Dr Rupert Vessey, EVP, Research & Early Dev., reported a sale of 30,546 shares in Bristol-Myers Squibb (BMY) for $1,963,802 on May 05, 2021. Dr Vessey, subsequent to the transactions disclosed in the SEC Form 4 filing, controls 45,757 shares of the company of which 45,139 shares are held directly and 618 shares are owned indirectly. The market value of the direct and indirect holdings, based on the prior-day closing price, is approximately $2.95 million.
During the most recent 90-day period, prior to the date of this filing, there have been 13 insider transactions reported to the SEC for Bristol-Myers Squibb. These transactions came from the activities of 13 individual insiders that resulted in a net acquisition of 194,891 company shares. In the preceding 90-day window of time, there were 24 transactions from 7 insiders and resulted in the net acquisition of 5,692 shares.
This level of transactions is below that of the peer group average in the 150-company Pharmaceuticals peer group over the last 90-day period. Peer group activity averaged 64.3 transactions per company, and disposition of 7,245 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/14272/000001427221000129/xslF345X03/wf-form4_162042099430812.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.